The Oncology Institute, Inc. (TOI)
Automate Your Wheel Strategy on TOI
With Tiblio's Option Bot, you can configure your own wheel strategy including TOI - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol TOI
- Rev/Share 0.5229
- Book/Share 0.0066
- PB 494.3207
- Debt/Equity 5.6051
- CurrentRatio 1.7941
- ROIC -0.4941
- MktCap 289880825.0
- FreeCF/Share -0.0248
- PFCF -15.1374
- PE -36.8617
- Debt/Assets 0.1732
- DivYield 0
- ROE -5.097
- Rating D+
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
---|---|---|---|---|---|---|---|
Initiation | TOI | BTIG Research | -- | Buy | -- | $7 | May 15, 2025 |
News
The Oncology Institute set to join the Russell 2000® and Russell 3000® Indexes
Published: June 03, 2025 by: GlobeNewsWire
Sentiment: Neutral
CERRITOS, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI”), one of the largest value-based oncology groups in the United States, today announced that it will join the Russell 2000® and Russell 3000® after the 2025 Russell indexes annual reconstitution, effective after the US market closes on June 27, according to a preliminary list of additions posted on May 23.
Read More
The Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025
Published: March 24, 2025 by: GlobeNewsWire
Sentiment: Neutral
CERRITOS, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its fourth quarter and year ended December 31, 2024.
Read More
The Oncology Institute Announces $16.5 million Private Placement
Published: March 24, 2025 by: GlobeNewsWire
Sentiment: Neutral
CERRITOS, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today announced it has entered into a securities purchase agreement (the “Securities Purchase Agreement”) with accredited investors for a private placement that is expected to result in gross proceeds of approximately $16.5 million, before deducting placement agent fees and offering expenses (the “Private Placement”). The Private Placement includes participation from existing investors, as well as members of the Company's management team and Board of Directors and is expected to close …
Read More
About The Oncology Institute, Inc. (TOI)
- IPO Date 2020-06-04
- Website https://theoncologyinstitute.com
- Industry Medical - Care Facilities
- CEO Dr. Daniel Virnich FACHE, M.B.A., M.D.
- Employees 825